Skip to content

Emergency Room HPV Self-Sampling Study (ACT NOW)

Feasibility and Effectiveness of HPV Self-Sampling for Cervical Cancer Screening Among Women Seeking Health Care At a Safety Net Hospital Emergency Room

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06178549
Acronym
ACT NOW
Enrollment
100
Registered
2023-12-21
Start date
2023-11-15
Completion date
2024-10-11
Last updated
2025-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer Screening

Brief summary

The goal of this study is to develop and evaluate an evidence-based public health intervention using HPV self-sampling approach in an opportunistic setting to increase cervical cancer screening among screening non-attendees, particularly those uninsured or underinsured, who use emergency services to access medical care. The proposed pilot study will examine the feasibility and efficacy of HPV self-sampling among women at a safety net hospital emergency room. Participant recruitment and self-sample will take place in the waiting rooms in the ER. All women sitting in the waiting room will serve as the source population for the study and will be approached and invited to participate in the study.

Interventions

HPV self-sampling. Participants will be provided with education regarding cervical cancer prevention and Aptima kit and instructions for self-sampling. Patient navigators will assist participants with positive HPV test results to connect with healthcare providers for follow-up screening and care.

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Eligible participants are women ages 25 years to 65 years, with a cervix, presenting in the waiting areas at the Ben Taub General Hospital Emergency Department

Exclusion criteria

* Women under 25 years or older than 65 years of age, * self-reported current pregnancy, * self-reported history of cervical cancer, * past hysterectomy, * had Pap Smear within past 3 years or HPV/Pap co-test within past 5 years.

Design outcomes

Primary

MeasureTime frameDescription
HPV self-sampling completion1 dayParticipation rate for self-sample HPV testing (percent of eligible women who complete self-sampling).

Secondary

MeasureTime frameDescription
HPV self-sampling acceptability1 dayacceptability of self-sample HPV testing using the global acceptability score
Attendance for cervical cancer screening among HR-HPV positive women6 monthsRate of attendance for cervical cancer screening among HR-HPV positive women (percent of HR-HPV positive participants who obtain a Pap test following self-sample HPV testing)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026